Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Le Min, Ph.D., M.Med.

Co-Author

This page shows the publications co-authored by Le Min and Ursula Kaiser.
Connection Strength

4.188
  1. RF9 Acts as a KISS1R Agonist In Vivo and In Vitro. Endocrinology. 2015 Dec; 156(12):4639-48.
    View in: PubMed
    Score: 0.634
  2. Corticosteroids and immune checkpoint blockade. Aging (Albany NY). 2015 Aug; 7(8):521-2.
    View in: PubMed
    Score: 0.627
  3. Computational Analysis of Missense Variants of G Protein-Coupled Receptors Involved in the Neuroendocrine Regulation of Reproduction. Neuroendocrinology. 2016; 103(3-4):230-9.
    View in: PubMed
    Score: 0.622
  4. Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res. 2015 Feb 15; 21(4):749-55.
    View in: PubMed
    Score: 0.601
  5. Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling. Mol Endocrinol. 2014 Jan; 28(1):16-27.
    View in: PubMed
    Score: 0.559
  6. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease. J Clin Endocrinol Metab. 2021 01 01; 106(1):e94-e102.
    View in: PubMed
    Score: 0.228
  7. The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders. Cancer Immunol Res. 2019 07; 7(7):1214-1220.
    View in: PubMed
    Score: 0.204
  8. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. Endocr Rev. 2019 02 01; 40(1):17-65.
    View in: PubMed
    Score: 0.200
  9. Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management. Cancer. 2018 03 15; 124(6):1111-1121.
    View in: PubMed
    Score: 0.185
  10. Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy. Cancer Immunol Res. 2017 12; 5(12):1133-1140.
    View in: PubMed
    Score: 0.183
  11. Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors. Endocrinology. 2017 07 01; 158(7):2284-2291.
    View in: PubMed
    Score: 0.045
  12. KISS1R signals independently of Gaq/11 and triggers LH secretion via the ß-arrestin pathway in the male mouse. Endocrinology. 2014 Nov; 155(11):4433-46.
    View in: PubMed
    Score: 0.037
  13. Single-cell analyses reveal that KISS1R-expressing cells undergo sustained kisspeptin-induced signaling that is dependent upon an influx of extracellular Ca2+. Endocrinology. 2012 Dec; 153(12):5875-87.
    View in: PubMed
    Score: 0.032
  14. GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1771-81.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.